Stephen Hoge
Dr. Stephen Hoge is the president of Moderna, a biotechnology company renowned for its development of mRNA vaccines, including those for COVID-19. He has been an advocate for the potential of mRNA technology to transform vaccine development, particularly for flu and other infectious diseases. Recently, he was in the news regarding the FDA's refusal to review Moderna's application for an mRNA seasonal flu vaccine, which he argued was inconsistent with previous communications from the agency.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Moderna’s president, Dr. Stephen Hoge, expressed surprise at the FDA's refusal to review their application for the mRNA flu vaccine.
7